Erin Dunbar, MD, director of Neuro-Oncology, Piedmont Atlanta Hospital, Atlanta, GA; Minesh Mehta, MD, chief of Radiotherapy, Baptist Health South Florida; Rohan Ramakrishna, MD, neurosurgeon, Weil Cornell Medical Center, New...
Mhairi Copland, MBChB, PhD, University of Glasgow, Glasgow, UK, discusses treatment options for blast phase CML, pointing out that TKI therapy alone with ponatinib has a 3-year survival rate of...
Mhairi Copland, MBChB, PhD, University of Glasgow, Glasgow, UK, suggests that patients with CML who respond to TKI therapy but experience bothersome side effects affecting quality of life may benefit...
In an interview conducted at the European Hematology Association Congress 2022 in Vienna, Austria, Fadi Haddad, MD, from MD Anderson Cancer Center, Houston, TX, discussed results from a study designed...
